Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF MAJORITY OWNED SUBSIDIARIES

The accompanying condensed consolidated financial statements include the accounts of MariMed Inc. and the following majority-owned subsidiaries at March 31, 2022:

 

Subsidiary:   Percentage
Owned		  
MariMed Advisors Inc.     100.0%  
Mia Development LLC     89.5%  
Mari Holdings IL LLC     100.0%  
Mari Holdings MD LLC     97.4%  
Mari Holdings NJ LLC     100.0%  
Mari Holdings NV LLC     100.0%  
Mari Holdings Metropolis LLC     70.0%  
Mari Holdings Mt. Vernon LLC     100.0%  
Mari Mfg LLC     100.0%  
Hartwell Realty Holdings LLC     100.0%  
iRollie LLC     100.0%  
ARL Healthcare Inc.     100.0%  
KPG of Anna LLC     100.0%  
KPG of Harrisburg LLC     100.0%  
MariMed OH LLC     100.0%  
MariMed Hemp Inc.     100.0%  
Meditaurus LLC     100.0%  
SCHEDULE OF ASSUMPTIONS USED

 

    Three Months Ended
March 31,		  
    2022     2021  
Life of instrument     *       3.0 to 5.0 years  
Volatility factors     *       1.230 to 1.266  
Risk-free interest rates     *       0.36% to 0.85%  
Dividend yield     *       0%  

 

* No options or warrants were issued by the Company during the three months ended March 31, 2022.